Surinabant
id:
surinabant-185-2810288
title:
Surinabant
text:
Surinabant (SR147778) is a cannabinoid receptor type 1 antagonist developed by Sanofi-Aventis. It is being investigated as a potential treatment for nicotine addiction, to assist smoking cessation. It may also be developed as an anorectic drug to assist with weight loss, however there are already several CB1 antagonists or inverse agonists on the market or under development for this application, so surinabant is at present mainly being developed as an anti-smoking drug, with possible application
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Surinabant
date created:
2008-05-07T05:19:09Z
date modified:
2024-09-07T15:48:15Z
main entity:
{"identifier":"Q7646304","url":"https://www.wikidata.org/entity/Q7646304"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/a1/Surinabant_Structure.svg","width":137,"height":139}
fields total:
13
integrity:
16